Surgical Sphincteroplasty Market Business Drivers, Top Companies and Competitive Analysis

Surgical Sphincteroplasty Industry Overview

The global surgical sphincteroplasty market size was valued at USD 1.3 billion in 2020 and is anticipated to expand at a compound annual growth rate (CAGR) of 6.6% from 2021 to 2028. The growing prevalence of Anal Incontinence (AI), cost-effectiveness of sphincteroplasty, and rising incidence of obstetric injury post-childbirth are the key factors driving the market. Anal Incontinence (AI) is a chronic condition that affects one out of every three individuals, according to the National Institute of Diabetes and Digestive and Kidney Diseases. Additionally, studies suggest that AI affects nearly 15% of women living in the community and half of the women in nursing homes. Factors such as age, obstetric trauma, pelvic surgery, chronic diarrhea, obesity, and other medical conditions, such as diabetes and stroke, increase the risk of Al.

India surgical sphincteroplasty market size, by type, 2018 - 2028 (USD Million)

AI is more commonly seen in women, due to the partial anterior disruption of both the internal and external sphincters caused by prolonged vaginal deliveries. Repair of the sphincters is likely to be the most effective treatment in such circumstances. It can be treated with surgical procedures such as Gluteoplasty, Stimulated Graciloplasty, and Sphincteroplasty. Other treatments include non-surgical procedures such as sacral nerve stimulation like Tibial Nerve Stimulation and InterSIM, use of biocompatible bulking agents such as Solesta, vaginal balloon insert, and artificial bowel sphincter. However, Sphincteroplasty (SP) is highly adopted among women and geriatric patients due to its high success rates, cost efficiency, and reduced need for re-surgery.

Gather more insights about the market drivers, restraints, and growth of the Global Surgical Sphincteroplasty Market

Studies suggest that sacral neuromodulation, anal encirclement, and treatment using a bulking agent, costs up to USD 20,000, whereas SP costs only up to USD 2000. Numerous researches are undertaken in the developed nation to establish an improved noninvasive method to cure AI, which is also expected to drive the market for surgical sphincteroplasty. Unfortunately, the outbreak of the Covid19 pandemic in 2020, halted clinical studies in developed nations. Additionally, the fear of virus spread among patients has led to the reduction in elective surgeries and reduced admission rates at hospitals, ultimately affecting the market in 2020. Decreased surgical supplies due to a halt in logistics, and lack of hospital care staff have led to the drop in the surgical sphincteroplasty market. However, it is said to improve steadily by mid-2022.

Browse through Grand View Research's Medical Devices Industry Related Reports

Microcurrent Facial Market - The global microcurrent facial market size was estimated at USD 372.9 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 7.3% from 2023 to 2030.

Blood Pressure Monitoring Devices Market - The global blood pressure monitoring devices market size was estimated at USD 4.5 billion in 2022 and is projected to expand further at a compound annual growth rate (CAGR) of 9.4% from 2023 to 2030.

Surgical Sphincteroplasty Industry Segmentation

Grand View Research has segmented the global surgical sphincteroplasty market based on type and region:

Surgical Sphincteroplasty Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Surgical (sphincteroplasty)
  • Non-Surgical

Surgical Sphincteroplasty Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA (Middle East & Africa)

Market Share Insights:

October 2021: Laborie Medical Technologies acquired Pevalon’s non-surgical segment Eclipse. The segment is responsible for marketing its largest grossing product, vaginal inserts, to treat incontinence among women.

Key Companies profiled:

Some prominent players in the global Surgical Sphincteroplasty Industry include

  • Medtronic
  • Hill-Rom Services, Inc.
  • McKesson
  • B. Braun
  • Becton, Dickinson and Company
  • Novo Surgical, Inc.
  • Surgical Holdings
  • Pelvalon
  • Salix Pharmaceutical Inc.
  • Johnson & Johnson

Order a free sample PDF of the Surgical Sphincteroplasty Market Intelligence Study, published by Grand View Research.

No comments:

Post a Comment

Analyzing the Impact of Corn Procurement on Revenue: A Forecasting Perspective

The Corn Category is expected to grow at a 3.1% CAGR from 2023 to 2030. The key factors driving corn demand are the rising demand for proce...